Clinical Trial Update: Angiotensin-II Blockade in Mitral Regurgitation [Phase 4]

View source ↗

Summary

Phase 4 trial investigating angiotensin-II blockade in patients with mitral regurgitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• Angiotensin II receptor blocker (ARB) (angiotensin II receptor blocker)

Snippet

Sponsor: Mayo Clinic | Conditions: Mitral Regurgitation | Phase 4 | Status: COMPLETED